Lifespan CEO: Failure of Lifespan-CNE merger was a factor in decision to step down

By The Boston Globe
| May 23, 2022

"It wasn't the only factor, and quite frankly, it wasn't the main factor. But it was a factor," Dr. Timothy Babineau said. "When that got blocked, knowing what lies ahead, I thought it was time for a change for me."

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

One of the most important elements of a company’s success is also one of the least tangible —culture. ...